| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
88,239 |
77,210 |
$3.12M |
| 99070 |
|
21,889 |
15,786 |
$2.17M |
| J3490 |
Unclassified drugs |
9,820 |
7,743 |
$1.60M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,438 |
9,256 |
$1.55M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,196 |
2,170 |
$1.54M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,116 |
11,179 |
$1.49M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,952 |
2,880 |
$1.18M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,921 |
26,742 |
$972K |
| 80053 |
Comprehensive metabolic panel |
48,741 |
44,785 |
$860K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,379 |
4,292 |
$846K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,036 |
5,846 |
$824K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,661 |
7,629 |
$685K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,289 |
10,876 |
$646K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
55,703 |
50,233 |
$619K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,314 |
8,636 |
$601K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,836 |
4,506 |
$515K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,298 |
3,002 |
$465K |
| 0450 |
Emergency room services |
10,527 |
9,503 |
$436K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,973 |
1,966 |
$417K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,519 |
5,295 |
$405K |
| G0378 |
Hospital observation service, per hour |
491 |
340 |
$392K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,056 |
2,935 |
$382K |
| 84484 |
|
19,698 |
15,919 |
$346K |
| 71045 |
Radiologic examination, chest; single view |
13,634 |
12,925 |
$322K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,000 |
1,827 |
$319K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20,792 |
11,160 |
$229K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,287 |
3,176 |
$222K |
| 83880 |
|
3,896 |
3,664 |
$207K |
| 71046 |
Radiologic examination, chest; 2 views |
3,964 |
3,868 |
$181K |
| Z7502 |
|
4,698 |
4,455 |
$170K |
| 99199 |
Unlisted special service, procedure or report |
2,994 |
2,888 |
$148K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,588 |
4,154 |
$145K |
| 83690 |
|
11,158 |
10,461 |
$131K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,120 |
1,112 |
$119K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,477 |
844 |
$116K |
| 87040 |
|
4,508 |
3,568 |
$112K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
4,279 |
3,406 |
$103K |
| 80306 |
|
3,439 |
3,263 |
$103K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,194 |
2,895 |
$93K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
711 |
707 |
$90K |
| 88342 |
|
1,421 |
1,391 |
$89K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,405 |
5,843 |
$84K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,054 |
2,732 |
$80K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,522 |
8,033 |
$75K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
35 |
35 |
$74K |
| 87088 |
|
6,266 |
6,039 |
$74K |
| 93971 |
|
518 |
512 |
$71K |
| 83605 |
|
3,930 |
3,631 |
$68K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,220 |
1,189 |
$67K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,222 |
3,897 |
$66K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,363 |
1,361 |
$65K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
815 |
757 |
$64K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,208 |
1,180 |
$64K |
| 0250 |
|
1,830 |
1,718 |
$61K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
184 |
183 |
$61K |
| 73562 |
|
1,734 |
1,610 |
$55K |
| 84703 |
|
4,168 |
3,967 |
$53K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,180 |
1,070 |
$53K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
773 |
701 |
$53K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
876 |
684 |
$50K |
| 0270 |
|
2,600 |
1,993 |
$50K |
| 81003 |
|
13,830 |
13,192 |
$48K |
| 96367 |
|
662 |
508 |
$48K |
| 82962 |
|
7,925 |
5,533 |
$47K |
| 87430 |
|
2,687 |
2,642 |
$47K |
| 81015 |
|
8,853 |
8,520 |
$46K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,078 |
4,829 |
$46K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
246 |
245 |
$44K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
702 |
667 |
$43K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,439 |
3,145 |
$42K |
| 73030 |
|
1,172 |
1,144 |
$40K |
| 70496 |
|
133 |
131 |
$40K |
| 71250 |
|
384 |
382 |
$39K |
| 0258 |
|
3,205 |
1,170 |
$37K |
| 70498 |
|
153 |
151 |
$37K |
| 73630 |
|
1,105 |
1,076 |
$37K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
374 |
364 |
$37K |
| 72131 |
|
332 |
331 |
$36K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,479 |
3,981 |
$33K |
| 74018 |
|
900 |
880 |
$33K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,587 |
1,519 |
$32K |
| 81001 |
|
5,608 |
5,423 |
$32K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
484 |
169 |
$30K |
| 87081 |
|
2,478 |
2,435 |
$30K |
| 85379 |
|
1,653 |
1,613 |
$30K |
| 73610 |
|
802 |
785 |
$29K |
| 72100 |
|
706 |
700 |
$29K |
| 80047 |
|
1,253 |
1,217 |
$29K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
57 |
56 |
$27K |
| 85610 |
|
4,126 |
3,910 |
$26K |
| 90715 |
|
396 |
394 |
$25K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
312 |
259 |
$25K |
| 85730 |
|
2,539 |
2,451 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,065 |
1,039 |
$24K |
| 87186 |
|
1,615 |
1,523 |
$23K |
| 76830 |
Ultrasound, transvaginal |
231 |
228 |
$21K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
263 |
256 |
$21K |
| 99218 |
|
520 |
263 |
$21K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
399 |
392 |
$20K |
| 84702 |
|
728 |
618 |
$20K |
| J1815 |
Injection, insulin, per 5 units |
1,624 |
885 |
$19K |
| 76770 |
|
239 |
239 |
$18K |
| 81025 |
|
2,432 |
2,368 |
$17K |
| 83735 |
|
1,589 |
1,459 |
$17K |
| 76801 |
|
138 |
133 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,226 |
1,200 |
$16K |
| 77080 |
|
141 |
141 |
$15K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
710 |
493 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
243 |
223 |
$14K |
| 87631 |
|
100 |
92 |
$13K |
| 73502 |
|
371 |
367 |
$13K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
145 |
140 |
$13K |
| 73130 |
|
350 |
339 |
$13K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
84 |
83 |
$12K |
| 87077 |
|
1,028 |
959 |
$12K |
| 70486 |
|
97 |
97 |
$11K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
100 |
87 |
$11K |
| 86900 |
|
1,925 |
1,710 |
$11K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,174 |
1,862 |
$11K |
| 73110 |
|
276 |
274 |
$10K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,920 |
1,788 |
$10K |
| 77065 |
Tomosynthesis, mammo |
57 |
55 |
$9K |
| 96523 |
|
181 |
146 |
$9K |
| 86901 |
|
1,925 |
1,711 |
$9K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
94 |
91 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
494 |
246 |
$8K |
| 94644 |
|
209 |
200 |
$8K |
| 99221 |
|
219 |
108 |
$8K |
| 93970 |
|
51 |
49 |
$8K |
| J2060 |
Injection, lorazepam, 2 mg |
1,454 |
1,321 |
$8K |
| 93798 |
|
130 |
24 |
$7K |
| 84439 |
|
522 |
509 |
$6K |
| 87641 |
|
207 |
181 |
$6K |
| 82553 |
|
309 |
274 |
$6K |
| 72110 |
|
101 |
101 |
$6K |
| 71020 |
|
141 |
110 |
$5K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12 |
12 |
$5K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
31 |
31 |
$5K |
| 73080 |
|
150 |
148 |
$5K |
| 94060 |
|
40 |
40 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
256 |
188 |
$5K |
| 86850 |
|
1,064 |
904 |
$5K |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
170 |
47 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
434 |
406 |
$4K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
235 |
235 |
$4K |
| 82805 |
|
91 |
90 |
$4K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
83 |
72 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
443 |
392 |
$4K |
| 77336 |
|
41 |
14 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
446 |
431 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
203 |
133 |
$3K |
| 76604 |
|
32 |
31 |
$3K |
| 72040 |
|
81 |
81 |
$3K |
| 97016 |
|
221 |
88 |
$3K |
| Z7610 |
|
201 |
184 |
$2K |
| 86140 |
|
376 |
364 |
$2K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
13 |
13 |
$2K |
| G0202 |
Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed |
18 |
18 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
200 |
117 |
$2K |
| 71101 |
|
54 |
54 |
$2K |
| 84145 |
|
56 |
54 |
$2K |
| J1453 |
Injection, fosaprepitant, 1 mg |
28 |
12 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,243 |
1,165 |
$1K |
| 76641 |
|
14 |
14 |
$1K |
| J1940 |
Injection, furosemide, up to 20 mg |
220 |
166 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
33 |
33 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
24 |
12 |
$1K |
| 73140 |
|
39 |
38 |
$1K |
| 97116 |
|
133 |
112 |
$1K |
| 82247 |
|
171 |
155 |
$1K |
| 94729 |
|
26 |
26 |
$956.31 |
| 76536 |
|
15 |
15 |
$936.32 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
67 |
46 |
$803.20 |
| 76870 |
|
15 |
14 |
$747.85 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
172 |
161 |
$740.91 |
| 82550 |
|
78 |
75 |
$716.23 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
47 |
38 |
$700.13 |
| 73590 |
|
13 |
13 |
$690.89 |
| 85652 |
|
192 |
182 |
$648.19 |
| 82310 |
|
112 |
112 |
$527.00 |
| 80061 |
Lipid panel |
53 |
51 |
$500.29 |
| 91200 |
|
12 |
12 |
$489.83 |
| 73564 |
|
12 |
12 |
$475.48 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
12 |
12 |
$420.80 |
| 82330 |
|
14 |
13 |
$388.92 |
| 80051 |
|
39 |
39 |
$387.23 |
| 82803 |
|
14 |
13 |
$376.60 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
55 |
53 |
$366.56 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$351.37 |
| 82947 |
|
71 |
69 |
$334.16 |
| J1630 |
Injection, haloperidol, up to 5 mg |
60 |
56 |
$324.32 |
| 73560 |
|
16 |
16 |
$281.61 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
47 |
42 |
$272.76 |
| 82565 |
|
56 |
56 |
$253.12 |
| 82010 |
|
26 |
25 |
$249.98 |
| 86308 |
|
28 |
28 |
$249.05 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
28 |
28 |
$202.45 |
| 84460 |
|
40 |
40 |
$160.12 |
| 84450 |
|
40 |
40 |
$154.27 |
| 84075 |
|
40 |
40 |
$145.05 |
| 84132 |
|
15 |
14 |
$124.96 |
| 84520 |
|
40 |
40 |
$113.55 |
| 84295 |
|
14 |
13 |
$111.58 |
| 85027 |
|
16 |
12 |
$89.94 |
| 87210 |
|
12 |
12 |
$88.88 |
| 87070 |
|
12 |
12 |
$85.25 |
| 82009 |
|
12 |
12 |
$72.08 |
| 85014 |
|
14 |
13 |
$68.32 |
| 87205 |
|
13 |
13 |
$39.25 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
209 |
193 |
$33.08 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12 |
12 |
$27.15 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
20 |
12 |
$23.64 |
| 0270R |
|
346 |
230 |
$0.00 |
| 0258R |
|
15 |
14 |
$0.00 |
| 0250R |
|
254 |
243 |
$0.00 |